| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
73 Outperform | £325.14M | 8.47 | 12.56% | 3.66% | 25.19% | 72.02% | |
69 Neutral | £127.04M | 13.93 | 8.96% | 2.05% | 5.25% | -7.14% | |
67 Neutral | £1.25B | 7.07 | 10.25% | 3.62% | -8.66% | 553.35% | |
61 Neutral | £218.82M | 15.87 | 20.71% | 3.59% | 5.96% | -2.01% | |
56 Neutral | £161.62M | -6.51 | -9.62% | ― | ― | ― | |
54 Neutral | £1.16B | 19.15 | 9.70% | 2.20% | 6.11% | 31.70% |